Royalty Pharma plc (RPRX) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 07:32 ET. Consensus EPS estimate is $1.16.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | FY2026 Q2 | $1.27 | $1.32 | +3.9% | $773.00M |
| 2026-05-06 | FY2026 Q1 | $1.21 | $1.30 | +7.4% | $925.00M |
| 2026-02-11 | FY2025 Q4 | $1.29 | $1.46 | +13.2% | $874.00M |
| 2025-11-05 | FY2025 Q3 | $0.99 | $1.17 | +17.7% | $609.29M |
| 2025-08-06 | FY2025 Q2 | $1.03 | $1.14 | +10.7% | $578.66M |
| 2025-05-08 | FY2025 Q1 | $0.95 | $1.06 | +11.2% | $568.25M |
| 2025-02-11 | FY2024 Q4 | $0.99 | $1.15 | +16.2% | $594.00M |
| 2024-11-06 | FY2024 Q3 | $0.93 | $1.04 | +12.1% | $564.69M |
RPRX has beaten consensus EPS in 8 of its last 8 reported quarters.
See RPRX on the live calendar →